Medicare Enrolled

Dr. Charles Richards, MD

Ophthalmology · Winston Salem, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
180 KIMEL PARK DR, Winston Salem, NC 27103
3363979700
Registered in NPPES since 2006
NPI: 1952315962 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Richards from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Richards? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Richards

Dr. Charles Richards is an ophthalmology specialist in Winston Salem, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Richards performed 19,651 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Richards received a total of $9,157 from 22 pharmaceutical and/or device companies across 145 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Richards is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 6% volume in NC $9,157 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
19,651
Medicare services
Top 6% in NC for ophthalmology
Not available
Unique patients (not deduplicated)
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
14,160 $29 $60
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,473 $28 $128
Aflibercept eye injection (Eylea) 1,070 $690 $1,308
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
878 $91 $183
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
858 $83 $345
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
450 $120 $218
Injection, ranibizumab, 0.1 mg 301 $180 $458
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
131 $119 $280
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
123 $25 $160
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
64 $16 $60
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
45 $1,762 $2,871
Unclassified biologic
A biologic product that does not have a specific HCPCS code assigned.
32 $2,109 $3,575
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
20 $11 $55
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
19 $168 $1,682
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $68 $134
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
13 $804 $4,624
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,157
Total received (2018-2024)
Avg $1,308/year across 7 years
Top 10% in NC for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
145
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,214
2023
$822
2022
$1,038
2021
$851
2020
$285
2019
$481
2018
$466

Payments by company (2024)

Genentech USA, Inc.
$2,547
EyePoint Pharmaceuticals US, Inc.
$2,240
Regeneron Healthcare Solutions, Inc.
$154
ABBVIE INC.
$79
Apellis Pharmaceuticals, Inc.
$72
Astellas Pharma US Inc
$53
Sandoz Inc.
$32
Bausch & Lomb Americas Inc.
$21
Notal Vision, Inc.
$16
Top 3 companies account for 94.8% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$3,558
EyePoint Pharmaceuticals US, Inc.
$2,343
Regeneron Healthcare Solutions, Inc.
$548
Notal Vision, Inc.
$497
Alimera Sciences, Inc.
$330
Allergan Inc.
$299
ABBVIE INC.
$196
Regeneron Pharmaceuticals, Inc.
$189
Mallinckrodt Hospital Products Inc.
$187
Heidelberg Engineering, Inc.
$166
Astellas Pharma US Inc
$154
Apellis Pharmaceuticals, Inc.
$138
Novartis Pharmaceuticals Corporation
$123
Allergan, Inc.
$101
Bausch & Lomb Americas Inc.
$77
Bausch & Lomb, a division of Bausch Health US, LLC
$75
Biogen, Inc.
$73
Sandoz Inc.
$32
Carl Zeiss Meditec AG
$19
MacuLogix, Inc.
$19
Horizon Therapeutics plc
$18
Vyera Pharmaceuticals, LLC
$17
Top 3 companies account for 70.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AdaptDx · BEOVU · Cimerli · DEXYCU · Daraprim Tablet 25mg · EYLEA · EYLEA HD · EYP-1901 · Foresee Home · ILUVIEN · Iluvien · Izervay · LOTEMAX · LOTEMAX SM · Lucentis · None Specified · OZURDEX · SUSVIMO · Spectralis · Syfovre · TEPEZZA · VABYSMO · VYZULTA · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Winston Salem?
Compare ophthalmologists in the Winston Salem area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
41
County median income
$65,541
Nearest hospital to ZIP centroid (approximate)
NOVANT HEALTH FORSYTH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Richards is a mixed practice specialist, with above-average Medicare volume (top 6% in NC), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Richards experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Richards performed 14,160 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Richards receive payments from pharmaceutical companies?
Yes. Dr. Richards received a total of $9,157 from 22 companies across 145 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Richards's costs compare to other ophthalmologists in Winston Salem?
Dr. Richards's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Richards) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →